Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
115,789,112
-
Total 13F shares
-
31,523,455
-
Share change
-
+2,481,285
-
Total reported value
-
$430,244,776
-
Put/Call ratio
-
75%
-
Price per share
-
$13.65
-
Number of holders
-
136
-
Value change
-
+$12,114,608
-
Number of buys
-
57
-
Number of sells
-
70
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q4 2018
As of 31 Dec 2018,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,523,455 shares.
The largest 10 holders included
ARK Investment Management LLC, BlackRock Inc., Vanguard Group Inc, FMR LLC, STATE STREET CORP, MORGAN STANLEY, ONTARIO TEACHERS PENSION PLAN BOARD, Atlas Venture Associates IX, LLC, Temasek Holdings (Private) Ltd, and Chevy Chase Trust Holdings, Inc..
This page lists
136
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.